|Bid||5.23 x 0|
|Ask||5.25 x 0|
|Day's Range||5.05 - 5.32|
|52 Week Range||4.00 - 11.56|
|Beta (3Y Monthly)||1.67|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.36 (6.81%)|
|1y Target Est||7.42|
Alcanna Inc. (the “Company” or “Alcanna”) (CLIQ.TO) today reported its results for the fourth quarter and full year ended December 31, 2018. Alcanna Inc. reported Canadian same-store sales growth of 7.4% and U.S. same-store sales growth of 6.0% in the fourth quarter of 2018. This was the Company’s best quarter of same-store sales growth in six years.
Lobo Genetics Inc. (“Lobo”), a leading cannabis healthcare technology company and Alcanna Inc. (“Alcanna”) (CLIQ.TO), owner of Nova Cannabis and one of the largest private sector retailers of alcohol in North America, are pleased to announce an industry-first partnership that brings direct-to-consumer cannabis genetic testing to Alcanna’s Nova Cannabis stores. Lobo’s cannabis test will help individuals understand how their bodies respond to THC, explain potential short-term and long-term risks based on their genetic profile, and explore other insights and recommendations to make more informed decisions about their cannabis use.
Taking the occasional loss comes part and parcel with investing on the stock market. And unfortunately for Alcanna Inc. (TSE:CLIQ) shareholders, the stock is a lot lower today than itRead More...
WKN: A1C4WM) today announced that it has agreed to terms to acquire a 51% ownership interest in Gaia Pharm Lda ., a license applicant in Portugal , to establish a local facility to produce medical cannabis and derivative products. The company will be renamed "Aurora Portugal Lda".
EDMONTON, Alberta, Feb. 21, 2019 -- Alcanna Inc. (the “Company") (TSX:"CLIQ") announced today that it will release its fourth quarter and year ended 2018 financial results.
Futures pointed to a flat opening for Canada's main stock index on Thursday, as investors await the United States and China to make progress in resolving their trade dispute. Officials have begun outlining ...
WKN: A1C4WM) announced today that Michael Singer , previously Chairman of the Board, has been appointed Executive Chairman of the Board of Directors. The Company also announced that independent director Ronald Funk has been named Lead Independent Director and Margaret ("Sha n") Atkins has been appointed as a new independent director and Chair of the Audit Committee.
WKN: A1C4WM) today announced that the Company's construction of a 300,000 square foot expansion at the Edmonton International Airport is progressing well. The new facility, named Aurora Polaris, is intended to serve as Aurora's centre of excellence for the industrial-scale production of higher margin, value added products, such as edibles which Health Canada regulations propose to permit from October 2019 onwards.
Aurora Cannabis Announces Confirmed Time for its Conference Call to Discuss Second Quarter 2019 Results
In 2016, Aurora identified Radient's proprietary extraction technology (MAP™) as potentially disruptive for the cannabis industry due to its ability to achieve much higher throughputs than is possible with existing benchmark technologies, as well as its efficiency and ability to preserve the full spectrum of cannabinoids and terpenes found in the source material.
"These convertible notes offer Aurora the flexibility and optionality to settle the entire principal amount of the notes in the future for cash, shares, or combination thereof," said Aurora CEO Terry Booth . Aurora expects to use the net proceeds from the offering of the notes to support its Canadian and international expansion initiatives, for future acquisitions and for general corporate purposes, including working capital requirements to continue the Company's accelerated growth.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more Read More...
The Company will issue US$300.0 million aggregate principal amount of notes, or US$345.0 million aggregate principal amount if the initial purchasers' over-allotment option is exercised in full. Aurora expects to use the net proceeds from the offering of the notes to support its Canadian and international expansion initiatives, for future acquisitions and for general corporate purposes, including working capital requirements to continue the Company's accelerated growth.
Aurora also intends to grant to the initial purchasers of the notes an option to purchase up to an additional US$37.5 million aggregate principal amount of notes. Aurora expects to use the net proceeds from the offering of the notes to support its Canadian and international expansion initiatives, for future acquisitions and for general corporate purposes, including working capital requirements to continue the Company's accelerated growth. The final terms of the notes will be determined by Aurora and the initial purchasers.
Alcanna Inc. (the “Company” or “Alcanna”) (CLIQ.TO), its subsidiaries, and Ace Liquor Corporation (“Ace”) have completed a series of transactions to form and vend stores into the Canadian Liquor Retailers Alliance Limited Partnership (the “Alliance”) as broadly contemplated in the Company’s November 8th, 2018 news release. In that release, the Company announced a non-binding letter of intent (“LOI”) with a discount liquor store operator in Alberta, Ace, to form a new partnership in the discount liquor store business.